# Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease

> **NCT02445547** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuzhou General Hospital** · enrollment: 82 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **OTHER:** UC-MSCs by peripheral intravenous infusion
- **DRUG:** received hormone maintenance therapy

## Key facts

- **NCT ID:** NCT02445547
- **Lead sponsor:** Fuzhou General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-06
- **Final completion:** —
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2017-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445547, "Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02445547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*